Literature DB >> 9572428

Serum vascular endothelial growth factor concentrations and ovarian stromal blood flow are increased in women with polycystic ovaries.

R Agrawal1, P Sladkevicius, L Engmann, G S Conway, N N Payne, J Bekis, S L Tan, S Campbell, H S Jacobs.   

Abstract

The aim of this study was to determine basal serum vascular endothelial growth factor (VEGF) concentrations and Doppler blood flow changes within the ovarian stroma of women with polycystic ovaries (PCO) and women with normal ovaries. Pulsed and colour Doppler blood flows within the ovarian stroma were recorded, and serum VEGF concentrations measured, in the early follicular phase (days 2-3 of a menstrual cycle) in 60 women undergoing ovarian stimulation for in-vitro fertilization. 36 women had normal ovaries, 14 women had PCO as seen on pelvic ultrasound examination and 10 had polycystic ovarian syndrome (PCOS). Mean+/-SD serum VEGF concentrations were significantly higher (P < 0.001) in women with PCO and PCOS (3.4+/-0.7 and 3.2+/-0.66 ng/ml respectively) compared with women with normal ovaries (2.3+/-0.5 ng/ml). Mean peak systolic blood flow velocity (PSV) and time-averaged maximum flow velocity (TAMXV) were significantly higher (P < 0.001) in women with PCO and PCOS compared with women with normal ovaries. The mean PSV were 15+/-4 and 16+/-4 cm/s in women with PCO and PCOS respectively, compared with 9+/-2 cm/s in women with normal ovaries. The TAMXV were 9+/-3 and 11+/-3 cm/s in women with PCO and PCOS respectively compared with women with normal ovaries (5.8+/-1.5 cm/s). Serum VEGF concentrations were positively correlated with PSV (r=0.44, P=0.001) and TAMXV (r=0.45, P < 0.000) in all three groups of women. Higher serum concentrations of VEGF in women with PCO and PCOS may relate to the increased vascularity that underlies the increased blood flow demonstrated by Doppler blood flow velocity measurements in these women. The results may explain the higher risk of ovarian hyperstimulation syndrome in programmes of ovarian stimulation in patients with PCO compared with those with normal ovaries.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9572428     DOI: 10.1093/humrep/13.3.651

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  24 in total

Review 1.  Cardiometabolic aspects of the polycystic ovary syndrome.

Authors:  Harpal S Randeva; Bee K Tan; Martin O Weickert; Konstantinos Lois; John E Nestler; Naveed Sattar; Hendrik Lehnert
Journal:  Endocr Rev       Date:  2012-07-24       Impact factor: 19.871

2.  SNAIL Mediates TGF-β1-Induced Downregulation of Pentraxin 3 Expression in Human Granulosa Cells.

Authors:  Hui Li; Hsun-Ming Chang; Zhendan Shi; Peter C K Leung
Journal:  Endocrinology       Date:  2018-04-01       Impact factor: 4.736

Review 3.  Ontogeny of the ovary in polycystic ovary syndrome.

Authors:  Daniel A Dumesic; Joanne S Richards
Journal:  Fertil Steril       Date:  2013-03-06       Impact factor: 7.329

4.  Nerve growth factor induces vascular endothelial growth factor expression in granulosa cells via a trkA receptor/mitogen-activated protein kinase-extracellularly regulated kinase 2-dependent pathway.

Authors:  Marcela Julio-Pieper; Patricia Lozada; Veronica Tapia; Margarita Vega; Cristián Miranda; David Vantman; Sergio R Ojeda; Carmen Romero
Journal:  J Clin Endocrinol Metab       Date:  2009-05-19       Impact factor: 5.958

5.  Differential expression of the angiogenic factor genes vascular endothelial growth factor (VEGF) and endocrine gland-derived VEGF in normal and polycystic human ovaries.

Authors:  Napoleone Ferrara; Gretchen Frantz; Jennifer LeCouter; Lisa Dillard-Telm; Thinh Pham; Aparna Draksharapu; Thomas Giordano; Franklin Peale
Journal:  Am J Pathol       Date:  2003-06       Impact factor: 4.307

6.  The vascular endothelial growth factor (VEGF) +405 G/C polymorphism and its relationship with recurrent implantation failure in women in an IVF programme with ICSI.

Authors:  Radia Boudjenah; Denise Molina-Gomes; Robert Wainer; Philippe de Mazancourt; Jacqueline Selva; François Vialard
Journal:  J Assist Reprod Genet       Date:  2012-10-27       Impact factor: 3.412

7.  Characterization of normal and polycystic ovaries using three-dimensional power Doppler ultrasonography.

Authors:  I Y Järvelä; H D Mason; P Sladkevicius; S Kelly; K Ojha; S Campbell; G Nargund
Journal:  J Assist Reprod Genet       Date:  2002-12       Impact factor: 3.412

8.  Effects of nerve growth factor (NGF) on blood vessels area and expression of the angiogenic factors VEGF and TGFbeta1 in the rat ovary.

Authors:  Marcela Julio-Pieper; Hernán E Lara; Javier A Bravo; Carmen Romero
Journal:  Reprod Biol Endocrinol       Date:  2006-11-10       Impact factor: 5.211

Review 9.  Involvement of androgens in ovarian health and disease.

Authors:  M Lebbe; T K Woodruff
Journal:  Mol Hum Reprod       Date:  2013-09-10       Impact factor: 4.025

Review 10.  A Narrative Review of Current Understanding of the Pathophysiology of Polycystic Ovary Syndrome: Focus on Plausible Relevance of Vitamin D.

Authors:  Rajeshwari Kalyanaraman; Lubna Pal
Journal:  Int J Mol Sci       Date:  2021-05-05       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.